Literature DB >> 7952867

Adaptive changes in 5-HT1A receptor-mediated hippocampal inhibition in the alert rat produced by repeated 8-OH-DPAT treatment.

D Manahan-Vaughan1, R Anwyl, M J Rowan.   

Abstract

1. The effect of acute and repeated treatment with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a 5-HT1A receptor ligand, on excitatory amino acid-mediated synaptic transmission was examined in the stratum radiatum CA1 region of the dorsal hippocampus of alert, gently restrained, rats. 2. Acute administration of 8-OH-DPAT transiently reduced the amplitude of the field excitatory postsynaptic potential (e.p.s.p.) in a dose-dependent (25-75 micrograms kg-1, i.p.) manner. This effect was blocked by the postsynaptic 5-HT1A receptor antagonist, MDL 73005EF (2 and 4 mg kg-1, i.p.). 3. 8-OH-DPAT (25 micrograms kg-1, i.p.) administered daily for 7 days produced a gradual reduction in the 24 h pre-injection baseline field e.p.s.p. amplitude. The reduction reached its lowest level after 7-8 days and was transiently reversed by acute injection of MDL 73005EF (2 mg kg-1, i.p.) on day 8. The field e.p.s.p. baseline amplitude recovered fully 5-8 days after cessation of drug treatment. 4. 8-OH-DPAT (25 micrograms kg-1, i.p.) administered daily for 7 days produced a marked reduction in acute response to 8-OH-DPAT (25 and 50 micrograms kg-1, i.p.) which did not recover until between day 36 and day 80 of the study. 5. It was concluded that repeated treatment with 8-OH-DPAT produced adaptive changes which resulted in a reduction in the dynamic range of 5-HT1A receptor-mediated transmission in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952867      PMCID: PMC1910231          DOI: 10.1111/j.1476-5381.1994.tb13194.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Anti-conflict efficacy of buspirone following acute versus chronic treatment.

Authors:  D M Schefke; D J Fontana; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.

Authors:  P Blier; A Lista; C De Montigny
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

3.  Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration.

Authors:  B Söderpalm; B Lundin; S Hjorth
Journal:  Eur J Pharmacol       Date:  1993-08-03       Impact factor: 4.432

4.  Use-dependent effects of acute and chronic treatment with imipramine and buspirone on excitatory synaptic transmission in the rat hippocampus in vivo.

Authors:  J J O'Connor; M J Rowan; R Anwyl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

5.  Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors.

Authors:  K Bohmaker; A S Eison; F D Yocca; E Meller
Journal:  Neuropharmacology       Date:  1993-06       Impact factor: 5.250

Review 6.  5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action?

Authors:  R Schreiber; J De Vry
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1993-01       Impact factor: 5.067

7.  Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats.

Authors:  Y Wada; M Nakamura; H Hasegawa; N Yamaguchi
Journal:  Neurosci Lett       Date:  1993-09-03       Impact factor: 3.046

8.  Agonist-induced down-regulation of human 5-HT1A and 5-HT2 receptors in Swiss 3T3 cells.

Authors:  F van Huizen; M T Bansse; N J Stam
Journal:  Neuroreport       Date:  1993-09-30       Impact factor: 1.837

9.  Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.

Authors:  R F Cox; E Meller; B L Waszczak
Journal:  Synapse       Date:  1993-08       Impact factor: 2.562

10.  Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.

Authors:  T Sharp; R McQuade; S Bramwell; S Hjorth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

View more
  3 in total

1.  Functional significance of glycogen synthase kinase-3 regulation by serotonin.

Authors:  Abigail M Polter; Sufen Yang; Richard S Jope; Xiaohua Li
Journal:  Cell Signal       Date:  2011-09-17       Impact factor: 4.315

Review 2.  5-HT1A receptor-regulated signal transduction pathways in brain.

Authors:  Abigail M Polter; Xiaohua Li
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

Review 3.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.